Showing 691-700 of 1376 results for "".
- Alisa Lask Joins CollPlant’s Board of Directorshttps://modernaesthetics.com/news/alisa-lask-joins-collplants-board-of-directors/2473137/Industry vet Alisa Lask is now a member of CollPlant’s Board of Directors. Ms. Lask is based in the United States and has held leadership roles in medical aesthetics at both Galderma and Allergan. She will be the seventh independent member of the CollPlan
- Sciton Launches mJOULE in Canadahttps://modernaesthetics.com/news/sciton-launches-mjoule-in-canada/2473136/Sciton Inc. is launching the new mJOULE platform in Canada. This system features the company's newest fractional treatment MOXI and BBL HERO treatment. "Part of Sciton's global growth strategy is to ensure our partners and their
- Study Tracks Increased Sadness, Fear, Disgust Among Healthcare Workers Linked to COVID-19https://modernaesthetics.com/news/study-tracks-increased-sadness-fear-disgust-among-healthcare-workers-linked-to-covid-19/2473134/Researchers discovered patterns of significantly decreased joy, increased sadness, fear and disgust among health care professionals (HCP) during the COVID-19 pandemic. The study, led by researchers at Ben-Gurion University of the
- Elite World Group Taps Elysium Health to Develop Science-First Skincare Linehttps://modernaesthetics.com/news/elite-world-group-taps-leading-elysium-health-to-develop-science-first-skincare-line/2473133/Elysium Health, Inc. is joining forces with Elite World Group to develop a line of skincare products. Launching in spring 2022, the line is currently in development and will be sold under an independent trademark. Elite World Group's talent media network, paired wit
- Kate Beckinsale Joins MRVL as the Face of its Anti-Aging Skin Care Linehttps://modernaesthetics.com/news/kate-beckinsale-joins-mrvl-as-the-face-of-its-anti-aging-skin-care-line-mrvl-skin-solutions/2473132/Kate Beckinsale is the face of MRVL Skin Solutions, an anti-aging skincare line launching this Fall. MRVL Skin Solutions is based on a novel ingredient in anti-aging: a Blue Scorpion Peptide. This peptide helps stimulate natural collagen production, fights free radicals, helps rege
- Alma Hybrid Launcheshttps://modernaesthetics.com/news/alma-hybrid-launches/2473128/Alma Hybrid™, the first laser platform to include an ablative 10,600nm (CO2) laser and a non-ablative 1570nm laser for skin resurfacing, in launching in the US. The system received FDA 510(k) clearance. Alma Hybrid offers p
- Price Transparency Webinar Goes Live on Thursday from BuildMyBod Healthhttps://modernaesthetics.com/news/price-transparency-webinar-goes-live-on-thursday-from-buildmybod-health/2473119/A webinar planned this week with Jonathan Kaplan, MD, founder of BuildMyBod Health, will help aesthetic physicians understand the role of automated cosmetic and insurance-based price listing on a practice website. As part of the educational program scheduled June 24 at 3pm EDT, attendee
- AACS Launches New Women in Cosmetic Surgery Sectionhttps://modernaesthetics.com/news/aacs-launches-new-women-in-cosmetic-surgery-section-new-women-in-cosmetic-surgery-section-for-members/2473117/The American Academy of Cosmetic Surgery (AACS) is launching a new forum to support the professional and personal development of female cosmetic surgeon members at all career levels. The AACS Women in Cosmetic Surgery Se
- GC Aesthetics Launches PERLE Breast Implantshttps://modernaesthetics.com/news/gc-aesthetics-launches-perle-breast-implants/2473106/GC Aesthetics is launching PERLE breast implants. PERLE smooth breast implants feature a proprietary surface technology (BioQ), GCA's industry-leading gel technology (Emunomic Breast Tissue Dynamic Gel), and an enhanced version of the safety features. PERLE is initially being rolled
- Forget Injectables, Patients with Benign Skin Lesions Want Them Gonehttps://modernaesthetics.com/news/forget-injectables-patients-with-benign-skin-lesions-prioritize/2473097/A majority of patients with unwanted benign lesions are interested in a new procedure to clear these lesions, according to a new survey by Pulse Biosciences that was presented at the American Academy of Dermatology (AAD) Virtual Annual Meeting. A diverse sample of 405 aesthetic patients